The trading price of Onconetix Inc (NASDAQ:ONCO) closed lower on Tuesday, March 25, and closing at $0.10, -17.53% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.0874 and $0.1175. In examining the 52-week price action we see that the stock hit a 52-week high of $21.40 and a 52-week low of $0.12. Over the past month, the stock has lost -75.30% in value.
Onconetix Inc, whose market valuation is $1.44 million at the time of this writing, is expected to release its quarterly earnings report in April. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest ONCO has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that ONCO’s price is currently -46.30% off the SMA20 and -75.32% off the SMA50. The RSI metric on the 14-day chart is currently showing 17.32, and weekly volatility stands at 15.22%. When measured over the past 30 days, the indicator reaches 13.46%. Onconetix Inc (NASDAQ:ONCO)’s beta value is currently sitting at 3.39, while the Average True Range indicator is currently displaying 0.04.
To see how Onconetix Inc stock has been performing in comparison to its peers in the industry, here are the numbers: ONCO stock’s performance was -17.53% in the latest trading, and -98.52% in the past year.
An evaluation of the daily trading volume of Onconetix Inc (NASDAQ:ONCO) indicates that the 3-month average is 10.40 million. However, this figure has increased over the past 10 days to an average of 6.49.
Currently, records show that 14.55 million of the company’s shares remain outstanding. The insiders hold 35.43% of outstanding shares, whereasinstitutions hold 2.64%. The stats also highlight that short interest as of 2025-02-28, stood at 0.21 million shares, resulting in a short ratio of 0.3 at that time. From this, we can conclude that short interest is 192.00 of the company’s total outstanding shares. It is noteworthy that short shares in February were down slightly from the previous month’s figure, which was 1.33 million. However, since the stock’s price has seen -84.32% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
